These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34983708)

  • 1. Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose.
    Gallagher MC; Haessler S; Pecoy-Whitcomb E; Bayuk J
    Allergy Asthma Proc; 2022 Jan; 43(1):37-39. PubMed ID: 34983708
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
    Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
    Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.
    Banerji A; Wickner PG; Saff R; Stone CA; Robinson LB; Long AA; Wolfson AR; Williams P; Khan DA; Phillips E; Blumenthal KG
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1423-1437. PubMed ID: 33388478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
    Pitlick MM; Joshi AY; Gonzalez-Estrada A; Chiarella SE
    Allergy Asthma Proc; 2022 Jan; 43(1):40-43. PubMed ID: 34983709
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience.
    Arroliga ME; Dhanani K; Arroliga AC; Huddleston PS; Trahan J; Aguilar T; Weldon D
    Allergy Asthma Proc; 2021 Sep; 42(5):395-399. PubMed ID: 34474708
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
    Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M
    JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine.
    Watts MM; Maurer LE; Grammer LC; Saltoun CA; Stevens WW
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):215-216. PubMed ID: 34699970
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
    Wang M; Wen W; Zhou M; Wang C; Feng ZH
    Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment and management of allergy history with a novel mRNA vaccine.
    Holt C; Butler J; Sharp K; McDonald J
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 35881510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience.
    ALMuhizi F; Fein M; Gabrielli S; Gilbert L; Tsoukas C; Ben-Shoshan M; Copaescu AM; Isabwe GAC
    Ann Allergy Asthma Immunol; 2022 Aug; 129(2):182-188.e1. PubMed ID: 35609744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis.
    Pienkowski MM; Pienkowski SM
    Ann Allergy Asthma Immunol; 2022 Jan; 128(1):101-103. PubMed ID: 34601091
    [No Abstract]   [Full Text] [Related]  

  • 15. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions.
    Pitlick MM; Sitek AN; D'Netto ME; Dages KN; Chiarella SE; Gonzalez-Estrada A; Joshi AY; Park MA
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):153-160. PubMed ID: 34798275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(4):125-129. PubMed ID: 33507892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
    Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on 'Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine'.
    Turkmen D; Altunisik N
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e606. PubMed ID: 35352400
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    Weiss SR
    JAMA; 2022 May; 327(20):2019-2020. PubMed ID: 35608592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.